To B or Not to B: Utility of PAX5 in Lineage Assignment of Acute Leukemia

被引：0

作者：

Cedeno, Ernest Hidalgo ^{[1
]}

Germans, Sharon Koorse ^{[2
]}

Pan, Zenggang ^{[3
]}

Weinberg, Olga ^{[2
]}

Xu, Mina ^{[4
]}

机构：

[1] Yale New Haven Hosp, Yale Sch Med, New Haven, CT USA

[2] UT SouthWestern Med Ctr, Dallas, TX USA

[3] Univ Colorado Anschutz Med Campus, Aurora, CO USA

[4] Yale Univ, New Haven, CT USA

来源：

LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1134

引用

页码：S1412 / S1413

页数：2

共 50 条

[31] Familial Predisposition to B-Cell Precursor Acute Lymphoblastic Leukemia Mediated By PAX5 Germline Variants
Auer, Franziska
Escuerdo, Adela
Friedrich, Ulrike Anne
Stepensky, Polina
Borkhardt, Arndt
Elitzur, Sarah
Takagi, Masatoshi
Hauer, Julia
BLOOD, 2022, 140 : 8888 - 8889
[32] Targeting Hyperactivated Lck in PAX5 Rearranged Pediatric B-Cell Precursors Acute Lymphoblastic Leukemia
Fazio, Grazia
Quadri, Manuel
Bresolin, Silvia
Palmi, Chiara
Bardini, Michela
Oikonomou, Athanasios
Tu, Jia-Wey
Scharov, Katerina
Peloso, Alberto
Watrin, Titus
Bhatia, Sanil
Borkhardt, Arndt
Biondi, Andrea
Cazzaniga, Giovanni
BLOOD, 2022, 140 : 3107 - 3108
[33] A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
Sohela Shah
Kasmintan A Schrader
Esmé Waanders
Andrew E Timms
Joseph Vijai
Cornelius Miething
Jeremy Wechsler
Jun Yang
James Hayes
Robert J Klein
Jinghui Zhang
Lei Wei
Gang Wu
Michael Rusch
Panduka Nagahawatte
Jing Ma
Shann-Ching Chen
Guangchun Song
Jinjun Cheng
Paul Meyers
Deepa Bhojwani
Suresh Jhanwar
Peter Maslak
Martin Fleisher
Jason Littman
Lily Offit
Rohini Rau-Murthy
Megan Harlan Fleischut
Marina Corines
Rajmohan Murali
Xiaoni Gao
Christopher Manschreck
Thomas Kitzing
Vundavalli V Murty
Susana C Raimondi
Roland P Kuiper
Annet Simons
Joshua D Schiffman
Kenan Onel
Sharon E Plon
David A Wheeler
Deborah Ritter
David S Ziegler
Kathy Tucker
Rosemary Sutton
Georgia Chenevix-Trench
Jun Li
David G Huntsman
Samantha Hansford
Janine Senz
Nature Genetics, 2013, 45 : 1226 - 1231
[34] Retroviral and Chemical Mutagenesis Identifies Pax5 as a Tumor Suppressor in B-Progenitor Acute Lymphoblastic Leukemia
Dang, Jinjun
Mullighan, Charles G.
Phillips, Letha A.
Mehta, Perdeep
Downing, James R.
BLOOD, 2008, 112 (11) : 256 - 257
[35] Transcriptional control of B cell identity by Pax5
Cobaleda, C
Delogu, A
Schebesta, A
Busslinger, M
IMMUNOLOGY, 2005, 116 : 30 - 31
[36] Pax5: the guardian of B cell identity and function
Cobaleda, Cesar
Schebesta, Alexandra
Delogu, Alessio
Busslinger, Meinrad
NATURE IMMUNOLOGY, 2007, 8 (05) : 463 - 470
[37] PAX5 expression in acute leukemias: Higher B-Lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia
Tiacci, E
Pileri, S
Orleth, A
Pacini, R
Tabarrini, A
Frenguelli, F
Liso, A
Diverio, D
Lo-Coco, F
Falini, B
CANCER RESEARCH, 2004, 64 (20) : 7399 - 7404
[38] Pax5: the guardian of B cell identity and function
César Cobaleda
Alexandra Schebesta
Alessio Delogu
Meinrad Busslinger
Nature Immunology, 2007, 8 : 463 - 470
[39] Mutations of PAX5 in LAL-B in adults
Familiades, J.
Bousquet, M.
Quelen, C.
Delsol, G.
Brousset, P.
Delabesse, E.
Broccardo, C.
BULLETIN DU CANCER, 2007, 94 : S298 - S298
[40] 5-Aza combined with VPA reprograms human T lineage acute leukemia Jurkat cells into B-cell-like cells by epigenetic activation of PAX5
Xi, Wenjin
Zheng, Guoxu
Chen, Xu
Zuo, Baile
Wang, Wei
Li, Yufang
Zhang, Chunmei
Chu, Jie
Mu, Xiuli
Wen, Weihong
Wang, Tao
Yang, An-Gang
BIOTECHNOLOGY PROGRESS, 2025,

← 1 2 3 4 5 →